ID: ALA3219495

Max Phase: Preclinical

Molecular Formula: C5H12N2O2

Molecular Weight: 132.16

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](NCCN)C(=O)O

Standard InChI:  InChI=1S/C5H12N2O2/c1-4(5(8)9)7-3-2-6/h4,7H,2-3,6H2,1H3,(H,8,9)/t4-/m1/s1

Standard InChI Key:  LWXIHPKOLTXDET-SCSAIBSYSA-N

Associated Targets(Human)

Glutamate [NMDA] receptor 933 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 132.16Molecular Weight (Monoisotopic): 132.0899AlogP: -0.99#Rotatable Bonds: 4
Polar Surface Area: 75.35Molecular Species: ZWITTERIONHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.23CX Basic pKa: 10.13CX LogP: -3.40CX LogD: -3.58
Aromatic Rings: 0Heavy Atoms: 9QED Weighted: 0.46Np Likeness Score: 0.11

References

1. Reymond J, van Deursen R, Blum LC, Ruddigkeit L.  (2010)  Chemical space as a source for new drugs,  (1): [10.1039/C0MD00020E]

Source